NDC 25021-174

daptomycin

Daptomycin

daptomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Daptomycin.

Product ID25021-174_db5f9dd2-bcc5-4e68-ac1c-02c8d77ddc9c
NDC25021-174
Product TypeHuman Prescription Drug
Proprietary Namedaptomycin
Generic NameDaptomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-03-15
Marketing CategoryANDA / ANDA
Application NumberANDA207104
Labeler NameSagent Pharmaceuticals
Substance NameDAPTOMYCIN
Active Ingredient Strength50 mg/mL
Pharm ClassesLipopeptide Antibacterial [EPC],Lipopeptides [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 25021-174-16

10 VIAL in 1 CARTON (25021-174-16) > 10 mL in 1 VIAL
Marketing Start Date2019-03-15
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
DAPTOMYCIN50 mg/mL

Pharmacological Class

  • Lipopeptide Antibacterial [EPC]
  • Lipopeptides [CS]

NDC Crossover Matching brand name "daptomycin" or generic name "Daptomycin"

NDCBrand NameGeneric Name
67919-011CubicinDaptomycin
67919-012CUBICIN RFDaptomycin
0409-0106DaptomycinDAPTOMYCIN
0703-0125DaptomycinDaptomycin
25021-174daptomycindaptomycin
25021-179DaptomycinDaptomycin
63323-371DaptomycinDaptomycin
63323-871DaptomycinDaptomycin
67457-813daptomycindaptomycin
70594-034DaptomycinDaptomycin
70594-053DaptomycinDaptomycin
43598-413DaptomycinDaptomycin
68001-376DaptomycinDaptomycin
63323-585DaptomycinDaptomycin
16714-892DaptomycinDaptomycin
16729-435DAPTOMYCINDaptomycin
71839-107daptomycindaptomycin
16729-434DaptomycinDaptomycin
45932-0039DaptomycinDaptomycin
57884-3151DaptomycinDaptomycin
69097-807DaptomycinDaptomycin
72572-100DaptomycinDaptomycin
72572-102DaptomycinDaptomycin

© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.